ProCE Banner Activity

My Approach to ALL Diagnosis and Initial Workup

Clinical Thought
Here’s my take on important considerations for ALL diagnosis and initial workup that inform treatment decisions.

Released: October 16, 2019

Expiration: October 14, 2020

Share

Faculty

Daniel J. DeAngelo

Daniel J. DeAngelo, MD, PhD

Professor of Medicine
Harvard Medical School
Chief, Division of Leukemia
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Jazz Pharmaceuticals, Inc.

Pfizer, Inc.

Faculty Disclosure

Primary Author

Daniel J. DeAngelo, MD, PhD

Professor of Medicine
Harvard Medical School
Chief, Division of Leukemia
Dana-Farber Cancer Institute
Boston, Massachusetts

Daniel J. DeAngelo, MD, PhD, has disclosed that he has received consulting fees from Amgen, Autolus Therapeutics, Celgene, Forty Seven, Incyte, Jazz, Novartis, Pfizer, Shire, and Takeda and funds for research support from AbbVie, GlycoMimetics, and Novartis.